VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...
One area that the company concentrates on is medical device engineering and the corresponding lab testing, evaluation and validation services. Devices such as training aids, medical diagnostic ...
The latest version of Instron’s Autoinjector Testing System was developed in close collaboration with CDMOs and pharmaceutical device manufacturers. It can perform thorough functioning testing on ...
Independent dermatology research experts at Monasterium Laboratory GmbH will test, analyze and validate various injection parameters using donated human tissue VANCOUVER, BC / ACCESSWIRE / November 11 ...
Elayne Gordonov, Market Manager - Global Bio Market at Instron, talks to AZoM about physical testing requirements of syringes, Luer connections, and needle-based injection systems in-line with ISO ...
Instron’s CT6 can be configured as an automated solution for the required testing of auto-injection devices – providing the benefits of automation without the additional complexity of a fully ...
Sacramento, Calif.-based Aerojet said Sept. 30 it had completed development injector testing for the 7,500-pound thrust Orion main engine (OME) for NASA’s Orion crew exploration vehicle. The test ...
Picotest has released a new test product designed to support high current demand Point of Load (POL) regulators and PDN measurements. Picotest has released a new test product designed to support high ...
Picotest has released a new test signal generator for EMI testing applications. Picotest has released a new test signal generator for EMI testing applications. The USB Harmonic Comb Injector, the ...
VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...
Initial units delivered and first phase of functional testing nearly complete VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / RepliCel Life Sciences Inc. (TSX.V:RP) (OTCPK:REPCF) (FRA:P6P2) ("RepliCel" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback